CCL2 and acute liver failure: In particular, MCP-1 and sSiglec-9 ameliorate rat acute liver failure by inhibiting hepatocellular apoptosis and promoting liver regeneration via the induction of anti-inflammatory/tissue-repairing M2 macrophages43.